Novel Class of Psychedelic Iboga Alkaloids Disrupts Opioid Addiction States
Mechanisms Preclinical high
AI-extracted · unverified · confirm at source
Columbia/Sames lab oxa-iboga alkaloids: synthetic variants maintain anti-addictive efficacy while reducing cardiac liability. Novel class development for safer analogues.
Safety data present: HERG